Akari Therapeutics plc has scheduled a general meeting of shareholders on December 15, 2025, to be held at 75/76 Wimpole Street, London. Shareholders will vote on several key proposals, including Resolution 5 concerning pre-emption rights and Resolution 6 regarding new articles.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-021316), on November 07, 2025, and is solely responsible for the information contained therein.